Citations [1] Minakova E, Lang J, Medel-Matus JS, et al
Acknowledgments The authors gratefully acknowledge the critical reviews and insights of Sarah Armstrong MD, Nancie MacIver MD PhD, and Lisa Rasbach PhD CPNP
It presents this as an exception requiring formal safeguards rather than as a routine option a patient can request

GPX4: Glutathione Peroxidase 4, GSH: glutathione, ROS: reactive oxygen species, IL-6: Interleukin-6, Interleukin-1 beta, TNF-: Tumor Necrosis Factor-alpha, MDA: malondialdehyde, TCL6: T-cell Leukemia/Lymphoma 6,TFRC: transferrin receptor, ALKBH5: AlkB Homolog 5, RNA, demethylase, FTL: ferritin light chain, SLC7A11: Solute Carrier Family 7 Member 11, ACSL4: Acyl-CoA, Synthetase Long Chain Family Member 4, HUVECs: Human Umbilical Vein Endothelial Cells, BaP: Benzo[a]pyrene, MARCHF1: Membrane Associated Ring-CH-Type Finger 1, VEGFA: Vascular Endothelial Growth Factor A, ANG-1: Angiopoietin-1, IGF2BP3: Insulin-like Growth Factor 2 mRNA-binding Protein 3, lnc-HZ06: Long Non-coding RNA HZ06, HIF1: Hypoxia-inducible Factor 1-alpha, NCOA4: Nuclear Receptor Coactivator 4, CRY2: Cryptochrome Circadian Regulator 2, BMAL1: Brain and Muscle ARNT-Like 1, TP53: Tumor Protein p53, EZH2: Enhancer of Zeste Homolog 2, TIMP1: Tissue Inhibitor of Metalloproteinases 1, SLC3A2: Solute Carrier Family 3 Member 2, GABARAPL2: GABA, Type A Receptor-Associated Protein Like 2, Fer-1: ferrostatin-1

113E6806E6812